Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy.
Merit Medical Systems Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$73.13|
|52 Week High||US$39.45|
|52 Week Low||US$73.85|
|1 Month Change||3.52%|
|3 Month Change||13.47%|
|1 Year Change||79.11%|
|3 Year Change||21.08%|
|5 Year Change||207.79%|
|Change since IPO||1,310.65%|
Recent News & Updates
Merit Medical: Nothing Flashy, But Solid Execution Supports The Story
Merit Medical is benefiting from a strong rebound in hospital procedures, and the company isn't as vulnerable to others from the recent surge in COVID-19 infections and hospitalizations. New product leverage and margin self-help remain important drivers, with SCOUT performing well and WRAPSODY data coming soon, while gross margin improvement efforts are currently challenged by input cost inflation. Healthy mid-single-digit revenue growth and mid-20%'s EBITDA margins can support a 4x forward revenue multiple, or a fair value close to $80.
Merit Medical Systems (NASDAQ:MMSI) Has More To Do To Multiply In Value Going Forward
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
|MMSI||US Medical Equipment||US Market|
Return vs Industry: MMSI exceeded the US Medical Equipment industry which returned 37.7% over the past year.
Return vs Market: MMSI exceeded the US Market which returned 36.2% over the past year.
Stable Share Price: MMSI is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: MMSI's weekly volatility (4%) has been stable over the past year.
About the Company
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, fluid management, electrophysiology and cardiac rhythm management, and hemodynamic monitoring to treat various heart conditions.
Merit Medical Systems Fundamentals Summary
|MMSI fundamental statistics|
Is MMSI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MMSI income statement (TTM)|
|Cost of Revenue||US$582.01m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.51|
|Net Profit Margin||2.74%|
How did MMSI perform over the long term?See historical performance and comparison
Is Merit Medical Systems undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: MMSI ($73.13) is trading above our estimate of fair value ($69.4)
Significantly Below Fair Value: MMSI is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MMSI is poor value based on its PE Ratio (145.7x) compared to the US Medical Equipment industry average (51.1x).
PE vs Market: MMSI is poor value based on its PE Ratio (145.7x) compared to the US market (17.7x).
Price to Earnings Growth Ratio
PEG Ratio: MMSI is poor value based on its PEG Ratio (3x)
Price to Book Ratio
PB vs Industry: MMSI is good value based on its PB Ratio (4.1x) compared to the US Medical Equipment industry average (4.7x).
How is Merit Medical Systems forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MMSI's forecast earnings growth (48.6% per year) is above the savings rate (2%).
Earnings vs Market: MMSI's earnings (48.6% per year) are forecast to grow faster than the US market (14.9% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MMSI's revenue (5.3% per year) is forecast to grow slower than the US market (9.8% per year).
High Growth Revenue: MMSI's revenue (5.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MMSI's Return on Equity is forecast to be low in 3 years time (9.5%).
How has Merit Medical Systems performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MMSI has a large one-off loss of $33.4M impacting its June 30 2021 financial results.
Growing Profit Margin: MMSI became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: MMSI's earnings have declined by 28.1% per year over the past 5 years.
Accelerating Growth: MMSI has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: MMSI has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (40.5%).
Return on Equity
High ROE: MMSI's Return on Equity (2.8%) is considered low.
How is Merit Medical Systems's financial position?
Financial Position Analysis
Short Term Liabilities: MMSI's short term assets ($449.8M) exceed its short term liabilities ($210.6M).
Long Term Liabilities: MMSI's short term assets ($449.8M) exceed its long term liabilities ($439.4M).
Debt to Equity History and Analysis
Debt Level: MMSI's debt to equity ratio (29.7%) is considered satisfactory.
Reducing Debt: MMSI's debt to equity ratio has reduced from 48.7% to 29.7% over the past 5 years.
Debt Coverage: MMSI's debt is well covered by operating cash flow (57.1%).
Interest Coverage: MMSI's interest payments on its debt are well covered by EBIT (12x coverage).
What is Merit Medical Systems's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MMSI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MMSI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MMSI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MMSI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MMSI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Fred Lampropoulos (71 yo)
Mr. Fred P. Lampropoulos has been the President of BioSphere Medical, Inc. since September 2010. He is Founder of Merit Medical Systems, Inc. and has been its Chairman, Chief Executive Officer and Presiden...
CEO Compensation Analysis
Compensation vs Market: Fred's total compensation ($USD7.70M) is above average for companies of similar size in the US market ($USD5.28M).
Compensation vs Earnings: Fred's compensation has been consistent with company performance over the past year.
Experienced Management: MMSI's management team is seasoned and experienced (5.8 years average tenure).
Experienced Board: MMSI's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: MMSI insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Merit Medical Systems, Inc.'s employee growth, exchange listings and data sources
- Name: Merit Medical Systems, Inc.
- Ticker: MMSI
- Exchange: NasdaqGS
- Founded: 1987
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$4.059b
- Shares outstanding: 56.27m
- Website: https://www.merit.com
Number of Employees
- Merit Medical Systems, Inc.
- 1600 West Merit Parkway
- South Jordan
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/23 22:57|
|End of Day Share Price||2021/09/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.